| Femcon FE Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Femcon FE 35 mcg-0.4 mg | tablet, chewable | oral | 1.0 each | OTC |
Posted by triste 2 days ago
Well,let me share my story about FEMCON FE ive been on the pill for about 4months NOw And my only side effect has been HEADAC...
Posted by roxyrocky 13 days ago
So glad to read this here. I have wondered the past year what is up with my face?!!! I have had problem skin in the past and ...
Posted by kdavis8339 17 days ago
My daughter has been taking this and started having bad stomach aches, gas and bloating. Anyone else have lots of gas?
Warner Chilcott Reports Operating Results for the Quarter and Year ... - MSN Money
We introduced and began commercial sales of FEMCON FE in the second half of 2006, but did not initiate promotional efforts in support of the product until ...
Fri Feb 29 07:08:35 -0500 2008
Warner Chilcott Announces 2008 Financial Guidance - HispanicBusiness.com (press release)
Total revenues for 2008 are expected to be in the range of $935 to $945 million, with the growth primarily being driven by LOESTRIN 24 FE, DORYX, FEMCON FE, ...
Tue Jan 29 17:26:56 -0500 2008
Warner Chilcott Announces 2008 Financial Guidance - CNNMoney.com
Total revenues for 2008 are expected to be in the range of $935 to $945 million, with the growth primarily being driven by LOESTRIN 24 FE, DORYX, FEMCON FE, ...
Mon Jan 28 07:37:41 -0500 2008
ethinyl estradiol - A semisynthetic estrogen. Ethinyl estradiol binds to the estrogen receptor complex and enters the nucleus, activating DNA transcription of genes involved in estrogenic cellular responses. This agent also inhibits 5-alpha reductase in epididymal tissue, which lowers testosterone levels and may delay progression of prostatic cancer. In addition to its antineoplastic effects, ethinyl estradiol protects against osteoporosis. In animal models, short-term therapy with this agent has been shown to provide long-term protection against breast cancer, mimicking the antitumor effects of pregnancy. (NCI04)
norethindrone - The acetate salt form of norethindrone, a synthetic progestational substance with some anabolic, estrogenic, and androgenic properties. Norethindrone binds to the progesterone intracellular receptors in the reproductive system and the resultant activated complex interacts with specific DNA sites. This leads to an alteration in protein synthesis and results in an inhibition of LH release. Consequently, it inhibits ovulation and changes the normal cycle of cervical mucus and endometrium.